I am a fairly large investor (6 figures) in NAN nanosonics, and as such know this company fairly well, but I don't understand how you can say they are a peers. IMO these two coy's are not ones that should be compared.
Nanosonics have developed a disinfection unit for ultrasound probes and are not in the business of discovering drugs (I use this term loosely).
The only similarities between the two are the fact that sales should start in earnest during the next quarter (hopefully).
Certain analysts may agree with you but I don't understand how you could compare them!!!!!
Your KPI's are only relevant if the company(s) are not about to change significantly in the near term.
Although you disagree, the holders of SLA think the revenue from SLA will increase enough in the near term to make their investment profitable.
I don't follow any of the other stocks you mentioned but to consider NAN as a peer to SLA means your naivety is worse than mine which is rather scary.
Maybe you could beter utilise the time you spend investing by reading the announcements instead of using search criteria on certain engines.
Comparing NAN to SLA is silly and you are better than that !
SLA Price at posting:
24.2¢ Sentiment: LT Buy Disclosure: Held